Foundation to Eradicate Duchenne
Non-Profit & Charitable Organizations · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 2371, Alexandria, Virginia, 22301...Website
www.duchennemd.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Foundation to Eradicate Duchenne
ReveraGen BioPharma Inc. is focused on developing first-in-class dissociative steroidal drugs for Duchenne muscular dystrophy (DMD) and other chronic inflammatory disorders. Their lead compound, vamorolone, has shown promising efficacy in clinical trials and is supported by partnerships with various foundations and government agencies. The company aims to provide innovative treatment options for patients suffering from DMD, a rare genetic disease primarily affecting young boys. ReveraGen collaborates with a wide range of stakeholders to advance drug development and improve patient outcomes.Explore more
Foundation to Eradicate Duchenne Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Foundation to Eradicate Duchenne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Foundation to Eradicate Duchenne had a recent Job posting/layoffs
Check out if Foundation to Eradicate Duchenne is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Foundation to Eradicate Duchenne
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Foundation to Eradicate Duchenne recently announced quarterly report
Funding: Get notified immidiatlly once Foundation to Eradicate Duchenne has new funding data
Product Launch: Get notified when Foundation to Eradicate Duchenne launches new products
Website visits: Recent activity has been detected on your website
Check if Foundation to Eradicate Duchenne has recently received funding, and reach out quickly before it becomes old news!
Foundation to Eradicate Duchenne, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Foundation to Eradicate Duchenne as Masked Content
Find 2 more new buyers
Compare Similar Companies to Foundation to Eradicate Duchenne
Compare insights from companies similar to Foundation to Eradicate Duchenne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Foundation to Eradicate Duchenne is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Foundation to Eradicate Duchenne is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Foundation to Eradicate Duchenne.
Foundation to Eradicate Duchenne Tech Stack
A closer look at the technologies used by Foundation to Eradicate Duchenne
See more technologies
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Foundation to Eradicate Duchenne
Sign Up For FreeTo access detailed company insights
ReveraGen BioPharma Inc. is focused on developing first-in-class dissociative steroidal drugs for Duchenne muscular dystrophy (DMD) and other chronic inflammatory disorders. Their lead compound, vamorolone, has shown promising efficacy in clinical trials and is supported by partnerships with various foundations and government agencies. The company... Read More
